Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) ("AHI" or the "Company") would like to inform shareholders that the Company will be expanding the current biometric assessment suite with on-mobile device Atrial Fibrillation (AF) service in quarter 2 of 2024 after signing a binding agreement with Qompium NV
Advanced Health Intelligence Ltd (ASX: AHI)（納斯達克股票代碼：AHI）（“AHI” 或 “公司”）謹通知股東，在與Qompium NV簽署具有約束力的協議後，公司將在2024年第二季度通過移動設備心房顫動（AF）服務擴展當前的生物識別評估套件
AHI will expand Biometric Health Assessment (BHA) with a mobile service for detecting atrial fibrillation and heart rhythm abnormality. • Up to 40% of atrial fibrillation (AF) patients are asymptomatici . • AHI will launch a Mobile Phone-Based AF-Scan for Atrial Fibrillation Assessment. • The application has medical approval in Australia, USA, Singapore, EU, UK, UAE and Saudi Arabia for near clinical. • The global prevalence of atrial fibrillation (AF) is approximately 60 million cases. ii • AF increases the risk of stroke five-fold.iii • AF is a prevalent arrhythmia affecting as many as 1 in 4 people over 40.iv
AHI 將擴大生物識別健康評估 (BHA) 的範圍，推出用於檢測心房顫動和心律異常的移動服務。• 高達 40% 的心房顫動 (AF) 患者無症狀。• AHI 將推出基於手機的 AF-Scan 進行心房顫動評估。• 該應用程序已在澳大利亞、美國、新加坡、歐盟、英國、阿聯酋和沙特阿拉伯獲得醫學批准接近臨床。• 心房顫動 (AF) 的全球患病率約爲 6,000 萬例。ii • 房顫使中風風險增加五倍。iii • 房顫很普遍心律失常影響超過 40.iv 的人，每四人中就有一人受到心律失常的影響